Wen-zhao F. Zhong
Advanced in Lung Metastases

Wen-zhao F. Zhong

106 Zhongshan 2nd Rd, 
Guangzhou, CN 
Advanced in Lung Metastases
106 Zhongshan 2nd Rd, 
Guangzhou, CN 
OverviewLocationsClinical Research

Overview

Wen-zhao Zhong practices in Guangzhou, China. Zhong is rated as an Advanced expert by MediFind in the treatment of Lung Metastases. Their top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Endoscopy, and Lymphadenectomy.

Their clinical research consists of co-authoring 220 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of Lung Metastases.

Locations

106 Zhongshan 2nd Rd, Guangzhou, 510080, China
Other Locations
106 Zhongshan 2nd Road, Guangzhou, 510080, China
Kongjiang Road 1665, Shanghai, 200092, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Neoadjuvant Sintilimab Plus Chemotherapy in EGFR-mutant Stage II-IIIB NSCLC: A Single-arm, Open-label Prospective Study
Neoadjuvant Sintilimab Plus Chemotherapy in EGFR-mutant Stage II-IIIB NSCLC: A Single-arm, Open-label Prospective Study
Enrollment Status: Active_not_recruiting
Publish Date: July 08, 2024
Intervention Type: Biological, Drug
Study Drugs: Sintilimab, Carboplatin, Nab Paclitaxel
Study Phase: Phase 2

220 Total Publications

Multiomics elucidation of surrounding AT2 cells impeding tertiary lymphoid structures function in neoadjuvant chemoimmunotherapy response of multiple primary lung cancers.
Multiomics elucidation of surrounding AT2 cells impeding tertiary lymphoid structures function in neoadjuvant chemoimmunotherapy response of multiple primary lung cancers.
Journal: Journal for immunotherapy of cancer
Published: September 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhong's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile